Blog

Justin Stebbing: Princess of Wales “in remission” from cancer

Justin Stebbing/healthpost.in

Jan 16, 2025, 13:38

Justin Stebbing: Princess of Wales “in remission” from cancer

Catherine, Princess of Wales, has shared the encouraging news that she is now in remission from cancer, after facing a challenging year of health issues.

Her cancer journey began with abdominal surgery in January 2024, which led her to step back from royal duties. In March, a cancer diagnosis was revealed, shocking many. After completing chemotherapy in September 2024, the princess has now reached a hopeful milestone in her recovery.

Justin Stebbing, visiting Professor of Cancer Medicine and Oncology at Imperial College, London and a Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge, shared an article about this case on The Conversation:

“Catherine, Princess of Wales, has announced that she is now in remission from cancer, following a year of health challenges for the royal family.

The princess’s cancer journey began with a planned abdominal surgery in January 2024, which initially led to her stepping back from royal duties. The subsequent cancer diagnosis, revealed in March, came as a shock to many. The princess announced that she had completed her chemotherapy treatment in September 2024.

Despite having exceptional resources and access to world-class medical care, Kate acknowledged the treatment as ‘incredibly challenging’ and ‘such a shock‘. Even with the best care and a supportive environment, chemotherapy is known for its potential side effects. Her candid admission demonstrates that even those in privileged positions are not immune to the physical and emotional toll of such treatments.

The princess’s latest statement, expressing relief at being in remission and focusing on recovery, reflects the complex emotions that often accompany this stage of the cancer journey. Her acknowledgement that it takes time to adjust to a ‘new normal’ resonates with many cancer survivors navigating life after treatment. This period of adjustment can involve physical recovery, emotional processing and a reevaluation of life priorities.”

Read the Full Article at theconversation.com.

Justin Stebbing is a visiting Professor of Cancer Medicine and Oncology at Imperial College, London and a Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge. He was appointed the first NIHR oncology professor in 2011.

He is editor-in-chief of Nature’s cancer journal Oncogene. Prof. Stebbing has published over 700 peer-reviewed papers in leading academic journals. He is a member of the American Society for Clinical Investigation, a fellow of the Royal College of Physicians, and the Royal College of Pathologists, and sits on many advisory boards. He is on the Editorial Board of OncoDaily.